Cargando…

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)

BACKGROUND: Liver transplantation is the definitive treatment for many end-stage liver diseases. However, the life-long immunosuppression needed to prevent graft rejection causes clinically significant side effects. Cellular immunomodulatory therapies may allow the dose of immunosuppressive drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popp, Felix C, Fillenberg, Barbara, Eggenhofer, Elke, Renner, Philipp, Dillmann, Johannes, Benseler, Volker, Schnitzbauer, Andreas A, Hutchinson, James, Deans, Robert, Ladenheim, Deborah, Graveen, Cheryl A, Zeman, Florian, Koller, Michael, Hoogduijn, Martin J, Geissler, Edward K, Schlitt, Hans J, Dahlke, Marc H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166276/ https://www.ncbi.nlm.nih.gov/pubmed/21798013 http://dx.doi.org/10.1186/1479-5876-9-124

Ejemplares similares

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation
por: Dillmann, Johannes, et al.
Publicado: (2012)

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
por: Eggenhofer, E., et al.
Publicado: (2012)

The Life and Fate of Mesenchymal Stem Cells
por: Eggenhofer, Elke, et al.
Publicado: (2014)

Mesenchymal stem cell-educated macrophages
por: Eggenhofer, Elke, et al.
Publicado: (2012)

The Role of Antioxidation and Immunomodulation in Postnatal Multipotent Stem Cell-Mediated Cardiac Repair
por: Saparov, Arman, et al.
Publicado: (2013)

La Physique au LHC - Partie I
por: Guillaume Unal
Publicado: (2004)

Augmenter of Liver Regeneration Reduces Ischemia Reperfusion Injury by Less Chemokine Expression, Gr-1 Infiltration and Oxidative Stress
por: Weiss, Thomas S., et al.
Publicado: (2019)

Hepatocellular carcinoma progression during bridging before liver transplantation
por: Renner, P, et al.
Publicado: (2021)

Working party on luminosity and background measurements in I-4
por: Sens, Johannes C
Publicado: (1971)

Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process
por: LoGuidice, Amanda, et al.
Publicado: (2016)

False Impressions: Chapter I.—Mrs. Lennox's Garden Party
por: Fothergill, Caroline
Publicado: (1888)

Retrograde stapling of a free cervical jejunal interposition graft: a technical innovation and case report
por: Hackl, Christina, et al.
Publicado: (2014)

IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes
por: Hsieh, Jenny, et al.
Publicado: (2004)

Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration
por: Eggenhofer, Elke, et al.
Publicado: (2021)

On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation
por: Engela, Anja U., et al.
Publicado: (2012)

Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
por: Weiss, Andreas Robert Rudolf, et al.
Publicado: (2019)

La Physique du Futur Collisionneur Linéaire e+e- Partie I
por: Henri Videau
Publicado: (2004)

Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
por: Kupke, Paul, et al.
Publicado: (2023)

Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response
por: Göcze, Ivan, et al.
Publicado: (2018)

Parties and party leaders
por: Morse, Anson Daniel
Publicado: (1923)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
por: Xiang, Shiqi, et al.
Publicado: (2022)

Bankable human iPSC-derived retinal progenitors represent a valuable source of multipotent cells
por: Gozlan, Sandy, et al.
Publicado: (2023)

Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells
por: Ravanidis, Stylianos, et al.
Publicado: (2017)

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells
por: Ravanidis, Stylianos, et al.
Publicado: (2015)

Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain
por: Jellema, Reint K., et al.
Publicado: (2015)

Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
por: de Witte, Samantha F. H., et al.
Publicado: (2016)

Fin de partie : suivi de, Acte sans paroles I /
por: Beckett, Samuel, 1906-1989
Publicado: (1957)

Perthamide C Inhibits eNOS and iNOS Expression and Has Immunomodulating Activity In Vivo
por: Bucci, Mariarosaria, et al.
Publicado: (2013)

A method for confirming a third‐party assay of I‐125 seeds used for prostate implants
por: Muryn, John S., et al.
Publicado: (2016)

Would I lie to you? Party affiliation is more important than Brexit in processing political misinformation
por: Prike, Toby, et al.
Publicado: (2023)

The grand old party – a party of values?
por: Mair, Patrick, et al.
Publicado: (2014)

Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012)

How to Make Sense out of 75,000 Mesenchymal Stromal Cell Publications?
por: Mönch, Dina, et al.
Publicado: (2022)

Mesenchymal Stromal Cell-Based Therapy
por: Mönch, Dina, et al.
Publicado: (2023)

Retraction: Perthamide C Inhibits eNOS and iNOS Expression and Has Immunomodulating Activity In Vivo
Publicado: (2019)

In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators
por: Zaki, Magdi E. A., et al.
Publicado: (2023)

Responses of Multipotent Retinal Stem Cells to IL-1β, IL-18, or IL-17
por: Chen, Shida, et al.
Publicado: (2015)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ium9ab476t47cn6ajdn06oe7j